- Report
- October 2024
- 156 Pages
Global
From €1976EUR$2,243USD£1,736GBP
€2635EUR$2,990USD£2,314GBP
- Report
- October 2024
- 139 Pages
Global
From €1976EUR$2,243USD£1,736GBP
€2635EUR$2,990USD£2,314GBP
- Report
- October 2023
- 136 Pages
Global
From €1652EUR$1,875USD£1,451GBP
€2203EUR$2,500USD£1,935GBP
- Report
- December 2022
- 323 Pages
Global
From €2776EUR$3,150USD£2,438GBP
€3701EUR$4,200USD£3,251GBP
- Report
- June 2022
- 264 Pages
Global
From €2313EUR$2,625USD£2,032GBP
€3084EUR$3,500USD£2,709GBP
- Report
- January 2024
- 211 Pages
Global
From €4891EUR$5,550USD£4,296GBP
- Report
- December 2019
- 62 Pages
India
- Report
- August 2024
- 298 Pages
China
From €3525EUR$4,000USD£3,096GBP
- Report
- September 2023
- 130 Pages
Global
From €5243EUR$5,950USD£4,605GBP
- Report
- September 2023
- 100 Pages
Global
From €5243EUR$5,950USD£4,605GBP
- Report
- July 2023
- 90 Pages
India
From €3481EUR$3,950USD£3,057GBP
- Report
- August 2024
- 322 Pages
Global
From €2776EUR$3,150USD£2,438GBP
€3701EUR$4,200USD£3,251GBP
- Report
- May 2024
- 134 Pages
Global
From €4868EUR$5,524USD£4,276GBP
€5727EUR$6,499USD£5,030GBP
- Report
- May 2024
- 128 Pages
Global
From €4868EUR$5,524USD£4,276GBP
€5727EUR$6,499USD£5,030GBP
- Report
- May 2024
- 138 Pages
Global
From €4868EUR$5,524USD£4,276GBP
€5727EUR$6,499USD£5,030GBP
- Report
- May 2024
- 129 Pages
Global
From €4868EUR$5,524USD£4,276GBP
€5727EUR$6,499USD£5,030GBP
- Report
- May 2024
- 131 Pages
Global
From €4868EUR$5,524USD£4,276GBP
€5727EUR$6,499USD£5,030GBP
- Report
- September 2023
- 105 Pages
Global
From €5243EUR$5,950USD£4,605GBP
- Report
- March 2023
- 100 Pages
Global
From €5243EUR$5,950USD£4,605GBP
- Report
- December 2024
- 140 Pages
Global
From €5243EUR$5,950USD£4,605GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more